Non-Small Cell Lung Cancer and Quality of Life (SILKE)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2009 by University of Turku.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
University of Turku
ClinicalTrials.gov Identifier:
NCT00818402
First received: January 5, 2009
Last updated: January 6, 2009
Last verified: January 2009
  Purpose

The principal objective is to study clinical observations, symptoms and quality of life of non-small-cell lung cancer (NSCLC) patients undergoing specific non-operative treatment for cancer, including chemotherapy and radiotherapy.


Condition
Non Small Cell Lung Cancer

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Treatment of Non-Small Cell Lung Cancer -Effects on Quality of Life and Symptom Control

Resource links provided by NLM:


Further study details as provided by University of Turku:

Biospecimen Retention:   Samples With DNA

whole blood


Estimated Enrollment: 200
Study Start Date: August 2008
Estimated Study Completion Date: September 2011
Estimated Primary Completion Date: September 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts
Non-small cell lung cancer patients

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

The patients treated in the clinic of respiratory medicine in Turku, Finland

Criteria

Inclusion Criteria:

  • Patients with verified NSCLC
  • after the NSCLC diagnosis has been confirmed prior to first chemotherapy or radiotherapy
  • Finnish speaking patients
  • aged 18 years or more
  • Written informed consent has to be signed

Exclusion Criteria:

  • Patients not consenting to participate in the study
  • patients not able to communicate sufficiently
  • cancer type is other than non-small-cell lung cancer
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00818402

Contacts
Contact: Maria Silvoniemi, MD +358 50 3442175 marber@utu.fi

Locations
Finland
Turku University Hospital, the Clinic of Resperatory Medicine Recruiting
Turku, Finland, 20521
Contact: Maria Silvoniemi       marber@utu.fi   
Sponsors and Collaborators
University of Turku
  More Information

No publications provided

Responsible Party: MD Maria Silvoniemi, University of Turku
ClinicalTrials.gov Identifier: NCT00818402     History of Changes
Other Study ID Numbers: SILKE-ETMK:47/180/2008
Study First Received: January 5, 2009
Last Updated: January 6, 2009
Health Authority: Finland: Ethics Committee

Keywords provided by University of Turku:
Quality of life
symptoms

Additional relevant MeSH terms:
Carcinoma, Non-Small-Cell Lung
Lung Neoplasms
Carcinoma, Bronchogenic
Bronchial Neoplasms
Respiratory Tract Neoplasms
Thoracic Neoplasms
Neoplasms by Site
Neoplasms
Lung Diseases
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on September 14, 2014